GCTK
GlucoTrack Inc
NASDAQ: GCTK · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.85
-7.26% today
Updated 2026-04-30
Market cap
$1.55M
P/E ratio
—
P/S ratio
526.95x
EPS (TTM)
$-31.22
Dividend yield
—
52W range
$1 – $14
Volume
3.5M
GlucoTrack Inc (GCTK) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $59775.00 | $143167.00 | $611689.00 | $589462.00 | $43488.00 | $208000.00 | $70778.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | +139.5% | +327.3% | -3.6% | -92.6% | +378.3% | -66.0% | -100.0% | — | — | — | — |
| Cost of revenue | — | — | — | $47.00 | $62484.00 | $65975.00 | $44891.00 | $59584.00 | $140209.00 | $95563.00 | $51000.00 | $47000.00 | $42000.00 | $23000.00 | $13000.00 | $36000.00 | — |
| Gross profit | — | — | — | $-47.00 | $-62484.00 | $-6200.00 | $98276.00 | $552105.00 | $449253.00 | $-52075.00 | $208000.00 | $-47000.00 | $-42000.00 | $-23000.00 | $-13000.00 | $-36000.00 | — |
| Gross margin | — | — | — | — | — | -10.4% | 68.6% | 90.3% | 76.2% | -119.7% | 100.0% | -66.4% | — | — | — | — | — |
| R&D | $1.01M | $934056.00 | $1.79M | $1.92M | $1.99M | $1.85M | $2.27M | $2.88M | $3.21M | $3.03M | $1.61M | $1.50M | $1.81M | $1.95M | $4.69M | $9.48M | $2.48M |
| SG&A | $165156.00 | $457495.00 | $544145.00 | $852908.00 | $1.04M | $1.69M | $2.25M | $3.23M | $7.76M | $3.48M | $1.49M | $1.14M | $2.12M | $2.45M | $2.27M | $4.63M | $6.28M |
| Operating income | $1.17M | $1.39M | $-2.33M | $2.77M | $3.03M | $3.61M | $4.66M | $5.66M | $10.58M | $6.54M | $3.51M | $-3.13M | $-4.04M | $-4.43M | $-7.10M | $-14.55M | $-16.09M |
| Operating margin | — | — | — | — | — | 6034.9% | 3251.7% | 924.6% | 1794.2% | 15035.4% | 1685.6% | -4425.1% | — | — | — | — | — |
| EBITDA | $-1.17M | $-2.50M | $-2.31M | $-2.73M | $-2.99M | $-3.57M | $-5.78M | $-5.33M | $-10.23M | $-6.64M | $-3.46M | $-2.65M | $-3.94M | $-4.41M | $-7.08M | $-21.98M | $-16.05M |
| EBITDA margin | — | — | — | — | — | -5976.9% | -4038.7% | -872.0% | -1736.1% | -15266.9% | -1661.1% | -3742.7% | — | — | — | — | — |
| EBIT | $1.17M | $-2.52M | $-2.33M | $-2.76M | $-3.03M | $-3.61M | $-5.83M | $-5.39M | $-10.30M | $-6.70M | $-3.51M | $-2.70M | $-3.98M | $-4.43M | $-7.10M | $-22.01M | $-16.09M |
| Interest expense | $32032.00 | $1.40M | $30893.00 | $6605.00 | $17592.00 | $6.59M | $15205.00 | $16216.00 | $24396.00 | $18290.00 | $10000.00 | $98000.00 | $4.16M | $3000.00 | $0.00 | $628000.00 | — |
| Income tax | $2.37M | $-2.78M | $30893.00 | $5.54M | $17592.00 | $-7.21M | $-1.27M | $16216.00 | $24396.00 | $-13.24M | $43.00 | $-98000.00 | $33000.00 | $3000.00 | $855000.00 | $22.60M | — |
| Effective tax rate | 202.7% | 49.9% | -1.3% | 200.2% | -0.2% | 170.4% | 17.8% | -0.3% | -0.2% | 66.3% | -0.0% | 3.5% | -0.8% | -0.1% | -13.7% | — | 0.0% |
| Net income | $-1.20M | $-2.79M | $-2.36M | $-2.77M | $-9.80M | $2.98M | $-5.84M | $-5.41M | $-10.33M | $-6.72M | $-3.52M | $-2.70M | $-4.07M | $-4.43M | $-7.10M | $-22.60M | $-19.39M |
| Net income growth (YoY) | — | -131.9% | +15.2% | -17.3% | -253.4% | +130.4% | -296.0% | +7.4% | -90.9% | +35.0% | +47.6% | +23.3% | -50.9% | -9.0% | -60.0% | -218.4% | +14.2% |
| Profit margin | — | — | — | — | — | 4986.1% | -4080.7% | -884.4% | -1752.2% | -15442.0% | -1690.4% | -3809.1% | — | — | — | — | — |